Cyclerion Therapeutics In... (CYCN)
NASDAQ: CYCN
· Real-Time Price · USD
2.39
0.06 (2.58%)
At close: Aug 15, 2025, 3:59 PM
2.39
0.00%
After-hours: Aug 15, 2025, 04:00 PM EDT
Cyclerion Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 93K | 81K | 1.81M | 194K | n/a | n/a | n/a | n/a | n/a | n/a | 1.63M | n/a | 72K | 225K | 182K | 77K | 3M | 62K |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 17K | 48K | 48K | n/a | n/a | n/a |
Gross Profit | n/a | 81K | 1.81M | 194K | n/a | n/a | n/a | n/a | n/a | n/a | 1.63M | n/a | 55K | 177K | 134K | 77K | 3M | 62K |
Operating Income | -1.67M | -1.46M | 502K | -1.13M | -1.38M | -1.62M | -1.79M | -6.01M | -4.24M | -7.04M | -7.35M | -10.61M | -13.43M | -12.98M | -14.34M | -11.29M | -16.18M | -13.39M |
Interest Income | 31K | 28K | 28K | 42K | 62K | 76K | 101K | 107K | 62K | 88K | n/a | 111K | 45K | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -324K | -1.43M | 530K | -723K | -1.32M | -1.54M | -1.69M | -5.91M | -4.18M | -6.95M | -7.22M | -10.5M | -13.39M | -12.98M | -10.78M | -11.29M | -16.18M | -13.4M |
Net Income | -324K | -1.43M | 530K | -723K | -1.32M | -1.54M | -1.69M | 7.57M | -4.18M | -6.78M | -7.03M | -10.27M | -13.34M | -12.97M | -10.78M | -11.29M | -16.18M | -13.4M |
Selling & General & Admin | 1.71M | 1.5M | 1.25M | 1.24M | 1.28M | 1.57M | 1.77M | 2.13M | 3.36M | 3.27M | 3.51M | 3.52M | 3.52M | 3.95M | 4.41M | 4.6M | 6.24M | 5.37M |
Research & Development | 56K | 36K | 56K | 81K | 105K | 44K | 24K | 580K | 886K | 3.77M | 4.45M | 7.08M | 10.22M | 9.74M | 10.46M | 7.03M | 12.05M | 8.09M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -608K | n/a | -234K | -486K | n/a | n/a | n/a | n/a |
Operating Expenses | 1.76M | 1.54M | 1.3M | 1.32M | 1.38M | 1.62M | 1.79M | 2.71M | 4.24M | 7.04M | 7.35M | 10.61M | 13.51M | 13.21M | 14.52M | 11.36M | 18.3M | 13.46M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 183K | n/a | 45K | 6K | 1K | 5K | 6K | 4K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.76M | 1.54M | 1.3M | 1.32M | 1.38M | 1.62M | 1.79M | 2.71M | 4.24M | 7.04M | 7.35M | 10.61M | 13.51M | 13.21M | 14.52M | 11.36M | 18.3M | 13.46M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -176K | -183K | -222K | -45K | -6K | 1K | n/a | 6K | n/a |
Shares Outstanding (Basic) | 3.07M | 2.56M | 2.55M | 2.53M | 2.51M | 2.49M | 2.47M | 2.44M | 2.28M | 2.18M | 2.18M | 2.07M | 2.07M | 2.07M | 2.06M | 2.16M | 1.79M | 1.7M |
Shares Outstanding (Diluted) | 3.07M | 2.56M | 2.55M | 2.53M | 2.51M | 2.49M | 2.47M | 2.44M | 2.28M | 2.18M | 2.18M | 2.07M | 2.07M | 2.07M | 2.06M | 2.16M | 1.79M | 1.7M |
EPS (Basic) | -0.11 | -0.56 | 0.21 | -0.29 | -0.53 | -0.62 | -0.68 | -3.36 | -1.83 | -3.11 | -3.23 | -4.97 | -6.46 | -6.28 | -5.23 | -5.22 | -9.06 | -7.86 |
EPS (Diluted) | -0.11 | -0.56 | 0.21 | -0.29 | -0.53 | -0.62 | -0.68 | -3.36 | -1.83 | -3.11 | -3.23 | -4.97 | -6.46 | -6.28 | -5.23 | -5.22 | -9.06 | -7.86 |
EBITDA | -1.67M | -1.46M | 502K | -1.13M | -1.38M | -1.54M | -1.69M | -2.71M | -4.24M | -7.04M | -7.47M | -10.61M | -13.43M | -12.93M | -10.73M | -11.24M | -15.18M | -13.14M |
EBIT | -324K | -1.46M | 502K | -1.13M | -1.38M | -1.62M | -1.79M | -2.71M | -4.18M | -6.95M | -7.35M | -10.5M | -13.43M | -12.98M | -11.65M | -11.29M | -15.29M | -13.39M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | 43.28K | 43.81K | 6.61M | 122.08K | 41.58K | -389K | 27.08K | 17K | 48K | 48K | 600K | 100K | 258K |